alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
REVIEW OF NIOSH’S PROGRAM 

EVALUATION REPORT 

DCAS-PER-038, “HOOKER 

ELECTROCHEMICAL TBD REVISION”

SC&A Report SCA-TR-PR2013, Rev. 0

Dated May 2013

Presented to the

Advisory Board’s Procedures Review Subcommittee

November 7, 2013

1
Document Chronology

• Site Profiles for Atomic Weapons Employers 

that Refined Uranium and Thorium –

Appendix AA Hooker Electrochemical 

Company. Battelle-TBD-6001, Appendix AA. 

June 15, 2007.

• Technical Basis Document for the Hooker 

Electrochemical Company, Rev. 0. DCASTKBS-0009. April 4, 2011.

2
Document Chronology (continued)

• Technical Basis Document for Hooker 

Electrochemical Company, Rev. 1. DCAS-TKBS0009. June 17, 2011.

• Hooker Electrochemical TBD Revisions. Program 

Evaluation Report. DCAS-PER-038. July 24, 2012.

• Review of the NIOSH Technical Basis Document 

for the Hooker Electrochemical Company, DCASTKBS-0009. SCA-TR-SP2013-0034, Rev. 0. March 

2013.

3
NIOSH Approach in OCAS-PER-038

• NIOSH developed criteria to screen claims that 

had been reviewed prior to the publication of 

DCAS-TKBS-0009 (June 2011) for the impact of 

any changes to dose reconstructions 

• 53 claims met screening criteria requiring further 

review

• 33 of these claims eliminated from consideration

• Probability of Causation (POC) recalculated for 20 

claims 

• POCs for all recalculated claims below 50%

4
SC&A Review 

• SC&A agrees that NIOSH’s screening criteria 

developed for OCAS-PER-038 are appropriate 

and the POC review based on these criteria 

was consistent with established procedures.

• However, NIOSH’s review for OCAS-PER-038 is 

based on Technical Basis Document for Hooker 

Electrochemical Company, Rev. 1. DCAS-TKBS0009. June 17, 2011.

5
SC&A Review (continued)

• Publication of PER preceded publication in 

March 2013 of SC&A’s findings based on 

review of Technical Basis Document for 

Hooker Electrochemical Company, Rev. 1.

• We believe that SC&A’s findings, which are 

based on new data, are substantive but have 

not been reviewed by NIOSH. 

6
SC&A Conclusion

• After SC&A’s findings have been resolved, it 

may be necessary to prepare a revised PER. 

7
| 1.   | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| August 18, 2009                              |
|----------------------------------------------|
|                                         |
|                                         |
| /s/ Natalie Russell                          |
| Natalie Russell                              |
| Chief Financial Officer and Secretary        |
| (Principal Financial and Accounting Officer) |
|                                         |
|                                         |
| /s/ James Winsor                             |
| James Winsor                                 |
| Chief Executive Officer                      |
| (Principal Executive Officer)                |
AGENDA 

Advisory Board on Radiation and Worker Health 

Teleconference Meeting of the 

Weldon Spring Work Group 

November 29, 2011 

Conference Call Number: 1-866-659-0537 Participant Pass Code: 9933701 

9:00 a.m. Welcome and roll-call/introductions 

Work Group Discussion 

1. Remaining issues from matrix: 

• Data completeness (1a)

• Blunders (1b - revised DCAS report) 

• Coworkers/unmonitored workers/unmonitored work periods (1d) 

• Radon model (4) 

• Neutron calculations (6) 

• Off/normal/accidents/incidents (8) 

2. Petitioner questions/comments

3. Report and Recommendations to the Board 

Adjourn
[Federal Register Volume 73, Number 25 (Wednesday, February 6, 2008)]
[Notices]
[Pages 6984-6985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-505]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 6985]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Special Grants Review Committee.
    Date: February 28-29, 2008.
    Time: 7:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Helen Lin, PhD, Scientific Review Administrator, 
NIH/NIAMS/RB, 6701 Democracy Blvd., Suite 800, Plaza One, Bethesda, 
MD 20817, 301-594-4952, <a href="/cdn-cgi/l/email-protection#fe92979096cfbe939f9792d0909796d0999188"><span class="__cf_email__" data-cfemail="bed2d7d0d68ffed3dfd7d290d0d7d690d9d1c8">[email protected]</span></a>.

    Dated: January 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-505 Filed 2-5-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit
32


Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted


Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002





In
connection with the Quarterly Report of BNH Inc. (the "Company") on Form 10-Q
for the fiscal period ended June 30, 2010, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Nehemya Hesin,
Chief  Executive and Financial Officer of the Company, certify
pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:





(1) the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:
      August 2,
    2010
                /s/
      Nehemya HesinNehemya HesinPresident, Treasurer and DirectorPrincipal Executive Officer and PrincipalFinancial and Accounting Officer
Order entered February 13 , 2017

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05
- 16
- 01112
- CV
IN THE INTEREST OF G .B., A CHILD

On Appeal from the 304th Judicial District Court

Dall as County, Texas Trial Court Cause No. JD
- 98
- 00657



### O RDER Before the Court is appellant’s February 10, 2017 motion for extension of time to file appellant’s supplemental brief. We GRANT appellant’s motion.
We ORDER the supplemental brief received on Janua ry 11, 2017 filed as of the date of
this order.
/s/ ELIZABETH LANG

- MIERS JUSTICE
#### State Of West Virginia *v.*Violet Lillian Romaca

(No. 14732)

Decided June 9, 1981.

*Thomas, Covert, King & Riffee and M. Joseph Thomas*for plaintiff.

*Chauncey H. Browning,*Attorney General, *Michael G. Clagett,*Assistant Attorney General, for defendant.

*120Pee Curiam:

Violet Lillian Romaca appeals from a 1978 misdemeanor manslaughter conviction in the Circuit Court of Kanawha County. Romaca’s motion to dismiss the misdemeanor manslaughter indictment was overruled. Romaca contends, as she did below, that she has a statutory right to be tried for the offense in magistrate court because the State first charged her with the offense by warrant in magistrate court. The State confesses error, recognizing Romaca is entitled to a reversal under our decisions in *State ex rel. Tate v.*Bailey,_W.Va._, 274 S.E.2d. 519 (1981) and *State ex rel. Burdette v. Scott,*168 W.Va. 705, 259 S.E.2d. 626 (1979). We agree that the trial court committed an error of law in overruling Romaca’s motion to dismiss the indictment and therefore we reverse and remand for further proceedings consistent with this opinion.

The facts are not in dispute and can be briefly stated. On January 10, 1978, a Kanawha County Magistrate issued a warrant charging Romaca with misdemeanor manslaughter arising out of a 1977 automobile accident which occurred in Kanawha County. Shortly thereafter petitioner appeared in person and by counsel in the Magistrate Court of Kanawha County and moved for continuance of the hearing on the warrant. The magistrate granted the motion and continued the case generally without fixing a date and time for any subsequent proceedings.

Romaca was subsequently indicted by the grand jurors attending the May 1978 Term of the Grand Jury of Kanawha County for misdemeanor manslaughter. This indictment concerned the identical matters previously charged in the warrant in rhagistrate court. She was convicted of the offense charged in October 1978 and was sentenced to one year in the Kanawha County j ail.

Our pronouncements in *Tate*and *Burdette*require a reversal of the judgment under review. We held there:

> “W.Va. Code, 50-5-7 (1976), requires that if a defendant is charged by warrant in the magistrate court with an offense over which that court has jurisdiction, he is entitled to a trial on the merits in *121the magistrate court.” Syl., *State ex rel. Tate v.*Bailey,_W.Va._, 274 S.E.2d 519 (1981), *citing,*Syl. pt. 2, *State ex rel. Burdette v. Scott,*163 W.Va. 705, 259 S.E.2d 626 (1979).

The magistrate court clearly had jurisdiction over the misdemeanor offense for which Romaca had been charged by warrant. Furthermore, Romaca did not waive her right to trial on the merits in magistrate court nor did that court relinquish its jurisdiction.

For the foregoing reasons, the judgement of the Circuit Court of Kanawha County is reversed and the case is remanded for further proceedings consistent with this opinion.

*Reversed and remanded.*
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5784 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 5784

 To designate the facility of the United States Postal Service located 
at 2650 North Doctor Martin Luther King Drive in Milwaukee, Wisconsin, 
            as the ``Vel R. Phillips Post Office Building''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 11, 2018

 Ms. Moore (for herself, Mr. Sensenbrenner, Mr. Duffy, Mr. Pocan, Mr. 
     Grothman, Mr. Gallagher, Mr. Kind, and Mr. Ryan of Wisconsin) 
 introduced the following bill; which was referred to the Committee on 
                    Oversight and Government Reform

_______________________________________________________________________

                                 A BILL

 
 To designate the facility of the United States Postal Service located 
at 2650 North Doctor Martin Luther King Drive in Milwaukee, Wisconsin, 
            as the ``Vel R. Phillips Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. VEL R. PHILLIPS POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 2650 North Doctor Martin Luther King Drive in Milwaukee, 
Wisconsin, shall be known and designated as the ``Vel R. Phillips Post 
Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Vel R. 
Phillips Post Office Building''.
                                 <all>
```
AGENDA

Advisory Board on Radiation and Worker Health – Meeting 80

Teleconference Meeting

October 20, 2011; 11:00 a.m. Eastern Time 

Teleconference Phone: 866-659-0537 

Participant Code: 9933701 

11:00 a.m. (Eastern Time) Start

• Roll-call – Mr. Katz, DFO

• Welcome – Dr. Melius, Chair

• Recording Absent Member Votes from August Meeting – Mr. Katz, DFO

• Pantex SEC Petition – Dr. Melius, Chair

--Petitioners: 

• Hangar 481 SEC Petition – Dr. Melius, Chair 

 --Petitioners:

• Special Exposure Cohort (SEC) Petition Status Update – Mr. Rutherford, DCAS

(On DCAS petition evaluations to be presented at the December 2011 Board meeting) 

• Updates from Work Groups and Subcommittees (as necessary) – WG/SC Chairs

• Board Correspondence – Dr. Melius, Chair

• Future Plans/Suggestions for the December 2011 Board Meeting Agenda – All 

Members
Exhibit 32.1

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

--------------------------------------------------------------------

In connection with the Quarterly Report of Global Warming Solutions, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Vladimir Vasilenko, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



(1)        The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)        The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





|Date: November 19, 2008 |  | By: /s/ Vladimir Vasilenko                                               
|----------------------- |  | -------------------------------------------------------------------------
|                        |  |                                                                          
|                        |  | Vladimir Vasilenko                                                       
|                        |  | Chairman, President Chief Executive Officer (Principle Executive Officer)



31



|
|
NIOSH Respiratory Protective Device Information

 NIOSH CA 2021-1037

 August 2021

 

Updated user instruction information regarding three NIOSH-approved 

filtering facepiece respirators TC-84A-9298, TC-84A-9308 and TC-84A-9315
Document Number

NIOSH CA 2021 - 1037

Page 2 of 2

The National Institute for Occupational Safety and Health (NIOSH) identified the following statement in 

the user instructions (UI) of three N95 approvals, recently issued to BNX Converting, LLC (BNX):

If you notice any air leakage, adjust the nosepiece and headbands until the leakage is corrected. Pull 

the headbands back, up, or, if necessary, shorten them by knotting”. “Once corrected, repeat the seal 

check again”. The instruction to shorten the headbands by knotting is not in agreement with the 

NIOSH Caution and Limitation N - Never substitute, modify, add, or omit parts. Use only exact 

replacement parts in the configuration as specified by the manufacturer. 

NIOSH failed to identify this concern prior to issuing the approvals. As a result, a limited number of 

respirators were distributed with UIs that include this instruction. On July 16, 2021 the approval 

holder, BNX Converting LLC, was informed about the concern and took immediate action to remove 

the problematic statement from the UIs. This notice is intended to notify users who may have 

received the previous instructions that if they cannot achieve a fit, the respirator should not be 

modified in any way to achieve a satisfactory fit.

The affected BNX approvals are:

TC-84A-9298 (Model A96)

TC-84A-9308 (Model A96-2)

TC-84A-9315 (Models H95W / H95B).

NIOSH is updating checklists used during the approval application review process to ensure going 

forward that these types of mistakes are caught before approvals are issued.

REFERENCE

NIOSH Certified Equipment List, General Limitations, Schedule 84A, Non Powered Particulate Filter

Respirators 

Updated user instruction information regarding three NIOSH-approved filtering 

facepiece respirators TC-84A-9298, TC-84A-9308, and TC-84A-9315
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

                    Section 30.13 of the Department of Health and Human Services' claims collection regulations (45 CFR Part 30) provides that the Secretary shall charge an annual rate of interest as fixed by the Secretary of the Treasury after taking into consideration private consumer rates of interest prevailing on the date that HHS becomes entitled to recovery. The rate generally cannot be lower than                           ( print page 5194)                        the Department of Treasury's current value of funds rate or the applicable rate determined from the “Schedule of Certified Interest Rates with Range of Maturities.” This rate may be revised quarterly by the Secretary of the Treasury and shall be published quarterly by the Department of Health and Human Services in the                     **Federal Register**                    .                

                    The Secretary of the Treasury has certified a rate of 12                    1/8                    % for the quarter ended December 31, 2007. This interest rate will remain in effect until such time as the Secretary of the Treasury notifies HHS of any change.                

Dated: January 16, 2008.

Molly P. Dawson,

Director, Office of Financial Policy and Reporting.

[FR Doc. 08-370 Filed 1-28-08; 8:45 am]

BILLING CODE 4150-04-M
**EXHIBIT 21.1**

**INKTOMI CORPORATION**

**SUBSIDIARIES**

C2B Technologies, Inc., a Delaware corporation, doing business under the name “Inktomi Corporation.”

Fast Forward Networks, Inc., a Delaware corporation, doing business under the name “Inktomi Corporation.”

Impulse! Buy Network, Inc., a California corporation, doing business under the name “Inktomi Corporation.”

Inktomi Australia Pty Limited, a corporation organized under the laws of Australia, doing business as “Inktomi Australia Pty Limited.”

Inktomi Canada Corporation, a corporation organized under the laws of New Brunswick, Canada, doing business as “Inktomi Canada Corporation.”

Inktomi Japan KK, a corporation organized under the laws of Japan, doing business as “Inktomi Japan KK.”

Inktomi Korea Inc., a corporation organized under the laws of Korea, doing business as “Inktomi Korea Inc.”

Inktomi Limited, a corporation organized under the laws of the United Kingdom, doing business as “Inktomi Limited.”

Ultraseek, Inc., a California corporation, doing business under the name “Inktomi Corporation.”

WebSpective Software, Inc., a Delaware corporation, doing business under the name “Inktomi Corporation.”

****
Exhibit 31.1  Section 302 Certification of Chief Executive Officer and Chief Financial Officer  1. I have reviewed this quarterly report on Form 10-Q of HPC POS System, Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;   (b) Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;   (c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and   (d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and  5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.    Dated:  February 17, 2011  /s/ Melvin W. Coles Melvin W. Coles Title: Chief Executive Officer and Chief Financial Officer
#### WALKER *v.*WALKER, WARDEN, et al.

No. 180, Misc.

Decided June 17, 1963.

Petitioner *pro se.*

*Jack P. F. Gremillion,*Attorney General of Louisiana, and *Scallan E. Walsh,*Assistant Attorney General, for respondents.

Per Curiam.

The motion for leave to proceed *in forma pauperis*and the petition for writ of certiorari are granted. The judgment is vacated and the case is remanded for further consideration in light of *Gideon*v. *Wainwright,*372 U. S. 335.